- Home
- BBDO vs GEHC Comparison
BBDO vs GEHC Comparison
Compare BBDO & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBDO | GEHC |
|---|---|---|
| Founded | 1943 | 1892 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6B | 29.1B |
| IPO Year | 2002 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BBDO | GEHC |
|---|---|---|
| Price | $3.04 | $65.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 13 |
| Target Price | N/A | ★ $88.38 |
| AVG Volume (30 Days) | 67.4K | ★ 3.1M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.88% | 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 0.85 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $70.86 | $7.12 |
| Revenue Next Year | $8.33 | $4.45 |
| P/E Ratio | ★ $9.20 | $78.56 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $2.65 | $58.75 |
| 52 Week High | $3.80 | $89.77 |
Technical Indicators
Market Signals| Indicator | BBDO | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 44.29 |
| Support Level | $2.97 | $60.17 |
| Resistance Level | $3.12 | $75.80 |
| Average True Range (ATR) | 0.09 | 1.29 |
| MACD | -0.02 | 0.23 |
| Stochastic Oscillator | 15.12 | 70.65 |
Price Performance
Historical ComparisonAbout BBDO Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation, a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).